NRx Pharmaceuticals shares gained after the company said it would buy California psychiatry clinic Kadima Neuropsychiatry Institute. The stock rose Thursday to $2.92, reaching a six-month high. Shares ...
Eupraxia Pharmaceuticals Inc. (NASDAQ:EPRX – Get Free Report) was the target of a significant growth in short interest in December. As of December 15th, there was short interest totalling 149,700 ...
Rangebound trading is expected to sustain in the upcoming sessions until the frontline indices give a strong close above all key moving averages. Below are some trading ideas for the near term.
Johnson & Johnson (JNJ) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.